Istesso Overview

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Reverse Merger
  • (Cancelled)

  • Financing Rounds
  • 7

Istesso General Information

Description

Developer of Immuno metabolism drugs intended to treat autoimmune and inflammatory conditions. The company's drugs specialize in the field of immune metabolism and treat rheumatoid arthritis and multiple sclerosis, enabling doctors and medical professionals to diagnose and treat deadly infections and disorders in an effective and efficient manner.

Contact Information

Formerly Known As
Modern Biosciences
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 3 Pancras Square
  • King's Cross
  • London N1C 4AG
  • England, United Kingdom
+44 020
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 3 Pancras Square
  • King's Cross
  • London N1C 4AG
  • England, United Kingdom
+44 020

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Istesso Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Istesso‘s full profile, request access.

Request a free trial

Istesso Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of Immuno metabolism drugs intended to treat autoimmune and inflammatory conditions. The company's drugs speci
Drug Discovery
London, United Kingdom
11 As of 2025

New York, NY
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Istesso Competitors (87)

One of Istesso’s 87 competitors is Xalud Therapeutics, a Venture Capital-Backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Xalud Therapeutics Venture Capital-Backed New York, NY
IFM Therapeutics Venture Capital-Backed Boston, MA
Laminar Pharma Venture Capital-Backed Palma de Mallorca, Spain
ImmunOs Therapeutics Venture Capital-Backed Schlieren, Switzerland
Plexium Venture Capital-Backed San Diego, CA
You’re viewing 5 of 87 competitors. Get the full list »

Istesso Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Istesso Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Istesso‘s full profile, request access.

Request a free trial

Istesso FAQs

  • Where is Istesso headquartered?

    Istesso is headquartered in London, United Kingdom.

  • What is the size of Istesso?

    Istesso has 11 total employees.

  • What industry is Istesso in?

    Istesso’s primary industry is Drug Discovery.

  • Is Istesso a private or public company?

    Istesso is a Private company.

  • What is Istesso’s current revenue?

    The current revenue for Istesso is .

  • How much funding has Istesso raised over time?

    Istesso has raised $13M.

  • Who are Istesso’s investors?

    Parkwalk Advisors, Puhua Capital, and IP Group have invested in Istesso.

  • Who are Istesso’s competitors?

    Xalud Therapeutics, IFM Therapeutics, Laminar Pharma, ImmunOs Therapeutics, and Plexium are some of the 87 competitors of Istesso.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process